PRODUCT

New 100G hardened muxponder from Optelian designed for 5G Upgrades, remote business services access and fibre deep architectures

Optelian has introduced the MPX-9103 100G hardened (OSP compliant) muxponder, which is designed for 5G upgrades, remote business services access and fibre deep architectures where 10G service growth is paramount.

The company says that the MPX-9103 solves the need for 100G applications where a temperature-controlled shelter or facility does not exist. With the capability to aggregate up to ten 10G client-side circuits onto a 100G line side interface, the 1 RU ‘pizza box’ provides one of the most cost effective outside plant (OSP) innovations to date. Further innovation within the MPX-9103 includes the ability to utilise commercially available 100G CFP transceivers for ultimate flexibility including SR, LR and DCO variants from a number of suppliers. It also provides full OTN capability.

Applications include upgrading cell site fronthaul and backhaul to 5G capability where bandwidth increases are expected to be significant. In addition, the MPX-9103 will allow service providers to now have flexibility with remote 100G capacity expansion without the expense of a fibre infrastructure upgrade where fibre relief may be necessary. The MPX-9103 dovetails with the company’s existing suite of hardened products for a whole system OSP solution.

The MPX-9103 has undergone NEBS qualification and is now widely available.

Company: 
Feature

Cost and compatibility can make a compelling case for pushing 100Gb/s bandwidth over a single optical channel, both as individual links and supporting 400Gb/s Ethernet, finds Andy Extance

Analysis and opinion
Analysis and opinion
Feature

Robin Mersh takes a look at how the industry is creating next-generation optical access fit for 5G

Feature

Technological advances to aid the increasing demand for bandwidth, on the path towards the terabit network, should lead to optical signals that are flexible and adaptive, like water, argues Dr Maxim Kuschnerov and Dr Yin Wang